Pharmaceuticals
GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours
NANJING, China, Feb. 6, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security officers, 8 transgenic mice for fully human antibodies immunized with antigen from 2019 nCoV from Rongchang District,Chongqing were brought by Chongqing Academy of Animal Sciences and Chongqing CAMA...
2020-02-06 22:46
1715
RhoVac Announces Appointment of Professor Anne J. Ridley to its Scientific Advisory Board
STOCKHOLM, Feb. 6, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, 6 th February 2020, the appointment of a leading oncology expert to its Scientific Advisory Board with the addition ofAnne J. Ridley, PhD, Professor of Cell Biology and Head of School of Cellular and Molecular Medicine, ...
2020-02-06 20:22
1420
Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer
MUMBAI, India, Feb. 6, 2020 /PRNewswire/ -- A new study
2020-02-06 08:00
2370
Bridge Biotherapeutics Acquires a New Drug Development Candidate for Back-Eye Diseases
* Signed a collaboration and license agreement for developing back-eye disease treatments with Konkuk University in the Republic of Korea * A total of 10B KRW deal includes 300M KRW of upfront payment SEONGNAM, South Korea, Feb. 5, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical ...
2020-02-05 13:21
1154
Christian Kinch Resigns as CEO of Bactiguard and is Proposed as New Chairman of the Board. Cecilia Edström Appointed New CEO
STOCKHOLM, Sweden, Feb. 5, 2020 /PRNewswire/ -- Christian Kinch today announced to the Board that he will resign as CEO of Bactiguard Holding AB (publ) after close to 16 years. The Board has appointed CFO and Deputy CEOCecilia Edström as new CEO of Bactiguard andStefan Grass (CMO) as Deputy CEO. ...
2020-02-05 06:38
11256
Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020
INCHEON, South Korea, Feb. 4, 2020 /PRNewswire/ -- Samsung Biologics, a pharmaceutical Contract Manufacturing Organization (CMO), recorded high for the fiscal year 2019, reporting 30.9% growth in sales at701.6 billion won, and 64.6% growth in operating profit at91.7 billion won compared to the ...
2020-02-04 13:50
1055
Pharmacy Alliance members come together in support of bushfire affected pharmacies & communities
SYDNEY, Feb. 4, 2020 /PRNewswire/ -- Pharmacy Alliance has established a
bushfire appeal, aiming to raise$250,000 to support bushfire affected
pharmacies in providing free medication and personal care items to their
communities.
2020-02-04 08:15
1782
China Jo-Jo Drugstores Steps in to Help Combat the 2019 Novel Coronavirus
HANGZHOU, China, Feb. 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina, today an...
2020-02-04 06:00
7934
Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases
SEATTLE, Feb. 4, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114. Trefoil is developing products based...
2020-02-04 06:00
1881
Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections
PLYMOUTH MEETING, Pennsylvania, Feb. 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of recurrent respiratory pap...
2020-02-03 21:00
2440
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies
Increased acceptance of outsourcing clinical trials predicted to propel sector revenues to$71.7 billion by 2024 SANTA CLARA, Calif., Feb. 3, 2020 /PRNewswire/ -- With an overall R&D expenditure of$167 billion in 2018, the global healthcare industry is investing heavily in the development of nove...
2020-02-03 17:01
1480
GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma
- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP) - Submission based on data from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) recently published inThe Lancet Oncology LONDON, Feb. 3,...
2020-02-03 17:00
9186
The Antimicrobial Crisis: New Antibiotics Could Avert 230,000 Deaths Per Year
Recent clinical studies presented at International Symposium organized by Fondazione Internazionale Menarini The World Health Organization warns: invest more and invest now in research to avoid catastrophic consequences for public health FLORENCE, Italy, Jan. 30, 2020 /PRNewswire/ -- The introdu...
2020-01-30 23:09
2471
Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China
Agreement will facilitate clinical trial translations in China PLYMOUTH MEETING, Pa., Jan. 30, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development inChina of INO-4800, Inovio'...
2020-01-30 19:00
4221
Infinitus donates 6 million yuan in cash and supplies to support prevention and treatment efforts in dealing with 2019-nCoV
GUANGZHOU, China, Jan. 29, 2020 /PRNewswire/ -- In the last few days, all attention inChina is focused on the prevention and treatment of the pneumonia caused by the novel coronavirus (2019-nCoV). Medical staff from both Wuhan and around the country, as well as people from all walks of life, are ...
2020-01-29 21:04
2200
XJTLU Researcher Adding Piece To Puzzle Of New Coronavirus
SUZHOU, JIANGSU, China, Jan. 29, 2020 /PRNewswire/ -- According to a researcher at Xi'an Jiaotong-Liverpool University, the Wuhan coronavirus, nCoV-2019, is closely related to SARS from the viewpoint of virus evolution. "Our findings suggest the nCoV-2019 lineage is related to the bat coronavir...
2020-01-29 12:06
2183
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
SHANGHAI, Jan. 29, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its efforts in enabling the development of multipl...
2020-01-29 10:00
3323
Systech Deploys First Serialization Lines for Takeda Pharmaceutical International AG to Meet New Russian Regulations
PRINCETON, New Jersey, Jan. 28, 2020 /PRNewswire/ -- Systech, the global technology leader in brand protection and digital product authentication, announced today it has successfully upgraded serialization lines forTakeda to meet new Russian serialization regulations.October 1, 2019 was the first...
2020-01-28 01:19
2494
SunGen and Camber Announce U.S. Launch of Generic Version of Bentyl® (Dicyclomine) Injection
PRINCETON, New Jersey, Jan. 25, 2020 /PRNewswire/ -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced the U.S. launch and commercial shipment of generic version of Bentyl® (Dicycl...
2020-01-25 06:16
1971
CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer's regorafenib
SUZHOU, China, Jan. 24, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) recently announced that it has dosed the first patient inAustralia in a clinical trial of CS1001, an investigational PD-L1 inhibitor developed by CStone, in combination with regorafenib, an...
2020-01-24 14:26
3511
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5608
